Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. [electronic resource]

By:

Okamoto, Isamu

Contributor(s):

Miyazaki, Masaki
Takeda, Masayuki
Terashima, Masaaki
Azuma, Koichi
Hayashi, Hidetoshi
Kaneda, Hiroyasu
Kurata, Takayasu
Tsurutani, Junji
Seto, Takashi
Hirai, Fumihiko
Konishi, Koichi
Sarashina, Akiko
Yagi, Nobutaka
Kaiser, Rolf
Nakagawa, Kazuhiko

Producer: 20151019Description: 346-52 p. digitalISSN:

1556-1380

Subject(s):

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Carcinoma, Non-Small-Cell Lung -- drug therapy
Docetaxel
Female
Humans
Indoles -- administration & dosage
Japan
Lung Neoplasms -- drug therapy
Male
Middle Aged
Taxoids -- administration & dosage

Online resources:

Available from publisher's website

In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 10

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer.

APA

Okamoto I., Miyazaki M., Takeda M., Terashima M., Azuma K., Hayashi H., Kaneda H., Kurata T., Tsurutani J., Seto T., Hirai F., Konishi K., Sarashina A., Yagi N., Kaiser R. & Nakagawa K. (20151019). Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Okamoto Isamu, Miyazaki Masaki, Takeda Masayuki, Terashima Masaaki, Azuma Koichi, Hayashi Hidetoshi, Kaneda Hiroyasu, Kurata Takayasu, Tsurutani Junji, Seto Takashi, Hirai Fumihiko, Konishi Koichi, Sarashina Akiko, Yagi Nobutaka, Kaiser Rolf and Nakagawa Kazuhiko. 20151019. Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Okamoto I., Miyazaki M., Takeda M., Terashima M., Azuma K., Hayashi H., Kaneda H., Kurata T., Tsurutani J., Seto T., Hirai F., Konishi K., Sarashina A., Yagi N., Kaiser R. and Nakagawa K. (20151019). Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Okamoto Isamu, Miyazaki Masaki, Takeda Masayuki, Terashima Masaaki, Azuma Koichi, Hayashi Hidetoshi, Kaneda Hiroyasu, Kurata Takayasu, Tsurutani Junji, Seto Takashi, Hirai Fumihiko, Konishi Koichi, Sarashina Akiko, Yagi Nobutaka, Kaiser Rolf and Nakagawa Kazuhiko. Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20151019.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC